Literature DB >> 17368876

Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.

Eleonora Vighi1, Barbara Ruozi, Monica Montanari, Renata Battini, Eliana Leo.   

Abstract

Cationic solid lipid nanoparticles (SLNs) have recently been suggested for non-viral gene delivery as a promising alternative to the liposomes. The aim of this study was to investigate the possibility to obtain re-dispersible cationic SLNs after a freeze-drying process in the absence of lyo- and/or cryoprotectors. The physical-chemical characteristics of cationic SLNs and their ability to bind gene material were investigated before and after the freeze-drying. To perform this study three samples of cationic SLNs, based on stearic acid, Compritol or cetylpalmitate, were prepared and characterized by PCS (photon correlation spectroscopy) and AFM (atomic force microscopy). The results indicated that solely the re-dispersed sample of stearic acid (SLN-SA) became very similar in terms of size and morphology to the fresh prepared sample, although it displayed a sensible reduction of the zeta potential (from 39.2 to 23.3 mV). By both the DSC (differential scanning calorimetry) and the ESCA (electron spectroscopy for chemical analysis) determinations, the reduction of the zeta potential was ascribed to the loss of the cationic lipids from the particle surface due to the rearrangement of the stearic acid lattice after the freeze-drying. Finally, the gel electrophoresis analysis demonstrated that SLN-SA re-suspended in PBS are unable to complex the DNA, while the SLN-SA re-dispersed in water displayed the same ability to bind DNA as the fresh prepared sample. We can conclude that cationic SLNs, based on stearic acid, retain the ability to complex DNA even after the freeze-drying in the absence of lyo- or cryoprotectors; thus, the powder form of this sample represents an attractive candidate to be investigated as in vivo DNA vector formulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368876     DOI: 10.1016/j.ejpb.2007.02.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  Solid lipid nanoparticles loaded with anti-microRNA oligonucleotides (AMOs) for suppression of microRNA-21 functions in human lung cancer cells.

Authors:  San-Jun Shi; Zhi-Rong Zhong; Jie Liu; Zhi-Rong Zhang; Xun Sun; Tao Gong
Journal:  Pharm Res       Date:  2011-07-06       Impact factor: 4.200

2.  Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells.

Authors:  Akhtar Siddiqui; Gauri Anand Patwardhan; Yong-Yu Liu; Sami Nazzal
Journal:  Int J Pharm       Date:  2010-09-15       Impact factor: 5.875

3.  A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2', 2'-difluorodeoxycytidine with increased solubility, stability, and antitumor activity.

Authors:  Solange A Valdes; Riyad F Alzhrani; Andres Rodriguez; Dharmika S P Lansakara-P; Sachin G Thakkar; Zhengrong Cui
Journal:  Int J Pharm       Date:  2019-08-12       Impact factor: 5.875

4.  Investigation of the potential therapeutic effect of cationic lipoplex mediated fibroblast growth factor-2 encoding plasmid DNA delivery on wound healing.

Authors:  Gülşah Erel-Akbaba; Hasan Akbaba
Journal:  Daru       Date:  2021-09-07       Impact factor: 4.088

5.  Stabilization of aerosolizable nano-carriers by freeze-drying.

Authors:  Claudia B Packhaeuser; Kerstin Lahnstein; Johannes Sitterberg; Thomas Schmehl; Tobias Gessler; Udo Bakowsky; Werner Seeger; Thomas Kissel
Journal:  Pharm Res       Date:  2008-10-08       Impact factor: 4.200

6.  Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection.

Authors:  Wei Wang; Fang Zhou; Linfu Ge; Ximin Liu; Fansheng Kong
Journal:  Int J Nanomedicine       Date:  2012-05-21

7.  Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.

Authors:  Yan Chen; Lei Zhou; Ling Yuan; Zhen-hai Zhang; Xuan Liu; Qingqing Wu
Journal:  Int J Nanomedicine       Date:  2012-06-19

8.  Lipid Nanoparticle Inclusion Prevents Capsaicin-Induced TRPV1 Defunctionalization.

Authors:  Carmelo Puglia; Debora Santonocito; Angela Bonaccorso; Teresa Musumeci; Barbara Ruozi; Rosario Pignatello; Claudia Carbone; Carmela Parenti; Santina Chiechio
Journal:  Pharmaceutics       Date:  2020-04-10       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.